|
|
Progress in research on zebrafish tumor model |
LI Cuixia SU Xiulan |
Clinical Medicine Research Center, the Affiliated Hospital of Inner Mongolia Medical University, Inner Mongolia Autonomous Region, Hohhot 010050, China |
|
|
Abstract Zebrafish have been successfully widely used as a research models for human-related diseases in the past decade due to their unique advantages in small-scale Organisms such as in vitro fertilization, embryo transparency and strong reproductive ability. At present, the gene manipulation technology for zebrafish has been quite mature, Targeting to induce or knock out certain genes in the body and change its expression level, it is easy to replicate some human tumor diseases on zebrafish, so various types of zebrafish tumor models can be established, and are suitable for conducfing reserch on related mechanisms. This article reviews the advantages of zebrafish as a tumor model and the research of various types of zebrafish tumor models, and the application value of zebrafish as a model animal in the study of anti-tumor drugs was analyzed.
|
|
|
|
|
[1] Bentley VL,Veinotte CJ,Corkery DP,et al. Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia [J]. Haematologica,2015,100(1):70-76.
[2] Veinotte C,Dellaire G,Berman J. Hooking the big one:the potentialofzebrafish xenotransplantation to reform cancer drug screening in the genomic era [J]. Dis Model Mech,2014, 7(7):745-754.
[3] Langenau DM,Traver D,Ferrando AA,et al. Myc-induced T cell leukemiain transgenic zebrafish [J]. Science,2003, 299(5608):887-890.
[4] Shen LJ,Chen FY,Zhang Y,et al. MYCN transgenic zebrafish model with the characterization of acute myeloid leukemia and altered hematopoiesis [J]. PloS One,2013, 8(3):59 070-59 082.
[5] 卿恺,陈芳源,沈莉菁,等.转Notch1基因T淋巴细胞白血病双荧光示踪斑马鱼模型的建立及鉴定[J].上海交通大学学报:医学版,2013,33(3):257-262,279.
[6] Tsao H,Fukunaga-Kalabis M,Herlyn M. Recent advances in melanoma and melanocyte biology [J]. J Invest Dermatol,2017,137(3):557-560.
[7] Gru AA,Becker N,Dehner LP,et al. Mucosal melanoma:correlation of clinicopathologic,prognostic,and molecular features [J]. Melanoma Res,2014,24(4):360-370.
[8] Olsen CM,Lane SW,Green AC. Increased risk of melanoma in patients with chronic lymphocytic leukaemia:systematic review and meta-analysis of cohort studies [J]. Melanoma Res,2016,26(2):188-194.
[9] Taylor KL,Lister JA,Zeng Z,et al. Differentiated melanocyte cell division occurs in vivo and is promoted by mutations in mitf [J]. Development (Cambridge,England),2011,138(16):3579-3589.
[10] Santoriello C,Gennaro E,Anelli V,et al. Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish [J]. PLoS One,2010,5(12):15170-15181.
[11] Ablain J,Durand EM,Yang S. A CRISPR/Cas9 vector system for tissue-specific gene disruption in zebrafish [J]. Dev Cell,2015,32(6):756-764.
[12] Ablain J,Zon LI. Tissue-specific gene targeting using CR-ISPR/Cas9 [J]. Methods Cell Biol,2016,135(1):189-202.
[13] Tan JL,Fogley RD,Flynn RA. Stress from Nucleotide depletion activates the transcriptional regulator HEXIM1 to suppress melanoma [J]. Mol Cell,2016,62(1):34-46.
[14] Zheng RS,Zuo TT,Zeng HM,et al. Mortality and survival analysis of liver cancer in China [J]. Chin J Oncol,2015,37(9):697-702.
[15] Zheng W,Li Z,Nguyen AT,et al. Xmrk,Kras and Myc transgenic Zebrafish liver cancer models share molecular signatures with subsets of human hepatocellular carcinoma [J]. PLoS One,2014,9(3):1-11.
[16] Jung DW,Oh ES,Park SH,et al. A novel zebrafish human tumor xenograft model validated for anti-cancer drug screening [J]. Mol Biosyst,2012,8(7):1930-1939.
[17] Huang X,Zhou L,Gong Z. Liver tumor models in transgenic zebrafish:an alternative in vivo approach to study hepatocarcinogenes [J]. Future Oncol,2012,8(1):21-28.
[18] Nguyen AT,Emelyanov A,Koh CH,et al. A high level of liver-specific expression of oncogenic Kras (V12)drives robust liver tumorigenesis in transgenic zebrafish [J]. Dis Model Mech,2011,4(6):801-813.
[19] Nguyen AT,Emelyanov A,Koh CH,et al. An inducible kras(V12)transgenic zebrafish model for liver tumorigenesis and chemical drug screening [J]. Dis Model Mech,2012,5(1):63-72.
[20] Wong CM,Sun L,Nguyen AT,et al. Myc-induced liver tumors in transgenic zebrafish can regress in tp53 null mutation [J]. PloS One,2015,10(1):1-17.
[21] Eeason KJ,Francisco MT,Juric V,et al. Identification of chemical inhibitors of β-catenin-drivenliver tumorigenesis in zebrafish [J]. PLoS Genet,2015,11(7):1005305.
[22] Ren J,Liu S,Cui C,et al. Invasive behavior of human breast cancer cells in embryonic zebrafish [J]. J Vis Exp,2017, 4(122):55 459-55 468.
[23] de Boeck M,Cui C,Mulder AA,et al. Smad6 determines BMP-regulated invasive behaviour of breast cancer cells in a zebrafish xenograft model [J]. Scientific Reports,2016,6(1):24 968-24 978.
[24] Li Y,Drabsch Y,Pujuguet P,et al. Genetic depletion and pharmacological targeting of alphav integrin in breast cancer cells impairs metastasis in zebrafish and mouse xenograft models [J]. Breast Cancer Res,2015,17(1):28-44.
[25] Hong SG,Noh HS,Teng Y,et al. SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells [J]. Neoplasia,2014, 16(4):279-290.
[26] Gnosa S,Capodanno A,Murthy RV,et al. AEG-1 knockdown in colon cancer cell lines inhibits radiationenhanced migration and invasion in vitro and in a novel in vivo zebrafish model [J]. Oncotarget,2016,7(49):81 634-81 644.
[27] 崔戈,谢珊珊,张婷,等.BAMBI基因过表达人结肠癌细胞移植斑马鱼致肝转移模型的构建[J].中华临床医师杂志,2015,9(21):3939-3945.
[28] Schiavone M,Rampazzo E,Casari A,et al. Zebrafi shreporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer [J]. Dis Model Mech,2014,7(7):883-894.
[29] Ignatius MS,Chen E,Elpek NM,et al. In vivo imaging of tumor-propagating cells,regional tumor heterogeneity,and dynamic cell movements in embryonal rhabdomyosarcoma [J]. Cancer Cell,2012,21(5):680-693.
[30] Storer NY,White RM,Uong A,et al. Zebrafish rhabdo-myosarcoma reflects the developmental stage of oncogene expression during myogenesis [J]. Development,2013,140(14):3040-3050. |
|
|
|